Plasmodium falciparum hemozoin formation pathway

The **Plasmodium falciparum hemozoin formation pathway** refers to a critical biochemical process by which the malaria parasite converts toxic free heme, released during hemoglobin digestion in the erythrocytic stage, into an inert crystalline pigment called **hemozoin** within the digestive vacuole[4]. This detoxification prevents buildup of cytotoxic heme and is essential for parasite survival in the blood stage[4][3]. Hemozoin is produced via protein- and lipid-facilitated mechanisms involving parasite enzymes such as falcipain 2, heme detoxification protein (HDP), and plasmepsins[2][4]. Disruption of hemozoin formation is the primary mechanism of action for major antimalarial drugs such as chloroquine and artemisinin, making this pathway a validated therapeutic target[3][5][6]. Drug resistance is a major therapeutic challenge for interventions targeting this pathway[5]. The process is also used in malaria diagnostics, as hemozoin pigment can be detected in patient blood samples[4].

Other names

Hemozoin biosynthesis pathwayHeme detoxification pathway in Plasmodium falciparumPlasmodium hemozoin pathway

Inhibition of hemozoin formation (e.g., quinoline drugs, DNA aptamers); Disruption of heme detoxification